EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy

Qiqing Yang, Bin Wang, Qinghui Zheng, Heyu Li, Xuli Meng, Fangfang Zhou, Long Zhang iD

Advanced Science · 2023-05 · 10 (15)

DOI: 10.1002/advs.202207366 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 23.03.2023. Verfasst von Qiqing Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery, Cancer Center, Department of Breast Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical C…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Microbiota, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 229-mal zitiert (Crossref) und nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of China, Chinese National Natural Science Funds, National Science Fund for Distinguished Young Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut microbiota‐derived metabolites are key hubs connecting the gut microbiome and cancer progression, primarily by remodeling the tumor microenvironment and regulating key signaling pathways in cancer cells and multiple immune cells. The use of microbial metabolites in radiotherapy and chemotherapy mitigates the severe side effects from treatment and improves the efficacy of treatment. Immunotherapy combined with microbial metabolites effectively activates the immune system to kill tumors and overcomes drug resistance. Consequently, various novel strategies have been developed to modulate microbial metabolites. Manipulation of genes involved in microbial metabolism using synthetic biology approaches directly affects levels of microbial metabolites, while fecal microbial transplantation and phage strategies affect levels of microbial metabolites by altering the composition of the microbiome. However, some microbial metabolites harbor paradoxical functions depending on the context (e.g., type of cancer). Furthermore, the metabolic effects of microorganisms on certain anticancer drugs such as irinotecan and gemcitabine, render the drugs ineffective or exacerbate their adverse effects. Therefore, a personalized and comprehensive consideration of the patient's condition is required when employing microbial metabolites to treat cancer. The purpose of this review is to summarize the correlation between gut microbiota‐derived metabolites and cancer, and to provide fresh ideas for future scientific research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeMicrobiotaNeoplasmsAntineoplastic AgentsHumansImmunotherapyTumor Microenvironment

Stichwörter der Autor:innen

cancer therapygut microbiota-derived metabolitesnovel strategiesparadoxical functionstumor progression

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • General Surgery, Cancer Center, Department of Breast Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, 310058, China.
  • MOE Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, Hangzhou, 310058, China.
  • Institutes of Biology and Medical Science, Soochow University, Suzhou, 215123, P. R. China.
  • International Biomed-X Research Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310058, China.
  • Center for Infection & Immunity of International Institutes of Medicine The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, China.
  • Cancer Center, Zhejiang University, Hangzhou, 310058, China.

ORCID-Profile: Long Zhang

Förderung

  • Ministry of Science and Technology of China
  • Chinese National Natural Science Funds
  • National Science Fund for Distinguished Young Scholars
  • Zhejiang Natural Science Fund
  • Key Construction Project Co-sponsored by Province and Ministry
  • General project of Zhejiang Health and Pharmaceutical Science and Technology Plan
  • Zhejiang Excellent Young Talents Fund for Traditional Chinese Medicine Project
  • Jiangsu Provincial Distinguished Young Scholars award

Zitieren

APA

Yang, Q., Wang, B., Zheng, Q., Li, H., Meng, X., Zhou, F., & Zhang, L. (2023). A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy. Advanced Science, 10(15). https://doi.org/10.1002/advs.202207366

Vancouver

Yang Q, Wang B, Zheng Q, Li H, Meng X, Zhou F, et al. A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy. Advanced Science. 2023;10(15). doi:10.1002/advs.202207366

BibTeX
@article{Yang2023,
  author = {Yang, Qiqing and Wang, Bin and Zheng, Qinghui and Li, Heyu and Meng, Xuli and Zhou, Fangfang and Zhang, Long},
  title = {A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy},
  journal = {Advanced Science},
  year = {2023},
  volume = {10},
  number = {15},
  doi = {10.1002/advs.202207366}
}
Kostenlos starten →